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Natural killer (NK) cells are vital components of the antiviral immune response, but their
contributions in defense against influenza A virus (IAV) are not well understood. To better
understand NK cell responses during IAV infections, we examined the magnitude, kinetics, and contribution of NK cells to immunity and protection during high- and low-dose
IAV infections. Herein, we demonstrate an increased accumulation of NK cells in the lung
in high-dose vs. low-dose infections. In part, this increase is due to the local proliferation
of pulmonary NK cells. However, the majority of NK cell accumulation within the lungs
and airways during an IAV infection is due to recruitment that is partially dependent
upon CXCR3 and CCR5, respectively. Therefore, altogether, our results demonstrate
that NK cells are actively recruited to the lungs and airways during IAV infection and
that the magnitude of the recruitment may relate to the inflammatory environment found
within the tissues during high- and low-dose IAV infections.
Keywords: natural killer cells, influenza virus, cell trafficking, lung, CXCR3, CCR5

INTRODUCTION
Natural killer (NK) cells, innate lymphocytes with cytolytic activity against infected and transformed
cells, have known roles in protection from DNA virus infections, including members of the herpesviridae, poxviridae, and papillomaviridae families (1–3). More recently, NK cells have been shown
to participate in the immune response against the orthomyxovirus influenza A virus (IAV), whose
segmented genome is composed of negative sense RNA. However, it is currently less clear as to
what contribution NK cells play [i.e., protective (4–11) vs. immunopathologic (12, 13)] in immunity
during IAV infections. While differences in animal models, virus strains, route of infection, and dose
of virus may explain the discrepancies between protective and immunopathologic effects, overall,
these studies all suggest that NK cells are a component of normal immunity to IAV.
Natural killer cell-mediated protection from infections requires effective NK cell recruitment
to the sites of lymphocyte activation and infection. NK cell recruitment to the liver is critical for
Abbreviations: BAL, bronchoalveolar lavage; BrdU, bromodeoxyuridine; CFSE, carboxyfluorescein succinimidyl ester; DLN,
draining lymph node; IAV, influenza A virus; mAb, monoclonal antibody; NK, natural killer; PBS, phosphate buffered saline;
p.i., post-infection; PT, pertussis toxin.
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MATERIALS AND METHODS

the control of both Toxoplasma gondii and murine cytomegalovirus, while recruitment to the draining lymph nodes (DLNs) in
ectromelia virus infection is important for priming an effective
CD8 T cell response (14–16). These data suggest that proper
NK cell trafficking is important for both the initial control of
infections at the replication site and the subsequent priming of
an adaptive immune response against the pathogen. Currently,
the mechanisms and molecular networks controlling NK cell
trafficking and accumulation in the lungs and draining lymphatics during IAV infection remain unclear. In general, NK cells
express many chemokine receptors, including CCR2, CCR5, and
CXCR3 that have been linked to NK cell migration (17). In the
lung tissue, CCR2 has been shown to be important for NK cell
recruitment and subsequent protection from invasive Aspergillus
fumigatus infections (18). While CCR2 has been shown to influence NK cell accumulation in the IAV-infected airway, its absence
had no effect on NK cell recruitment to the IAV-infected lung
parenchyma (19). This suggests that the mechanism of NK cell
recruitment may differ between pulmonary infections. CXCR3
is known to be important in NK cell recruitment to the lung in
homeostasis, as CXCR3−/− mice have significantly fewer NK cells
in the lungs than WT mice (20). While NK cell expression of
CXCR3 can result in an increased NK cell accumulation in the
lungs during pulmonary inflammation (20, 21), the importance
of CXCR3 in recruiting NK cells to the lung during IAV infection has not yet been determined. In addition to recruitment to
individual organs, chemokine receptors can localize cells within
an organ. For example, while CXCR3 expression is important in
CD8 T cell recruitment to the lung, CCR5 expression on CD8
T cells is required for the localization of memory CD8 T cells to
the IAV-infected epithelium (22, 23). While it has been shown
that CCR5−/− NK cells are better able to proliferate in the IAVinfected lung compared to those in WT (24), the role of CCR5 in
NK cell recruitment to and localization within the IAV-infected
lung has not been directly examined.
As the dose of virus may affect how NK cells contribute to
IAV immunity, we herein examined if IAV infection dose alters
NK cell recruitment to lungs, lung DLNs, and spleen. Given the
importance of CXCR3 in NK cell homeostasis, and the role of
CXCR3 and CCR5 in recruiting and localizing CD8 T cells to
the lung during IAV infection, we specifically determined if
CXCR3 and CCR5 are required for NK cell recruitment during
both high- and low-dose IAV infections. Our results demonstrate
that while NK cells accumulate in the lung and DLN during both
high- and low-dose IAV infections, a greater NK cell accumulation occurs in the lungs during high-dose infections and in the
DLN during low-dose infections. CXCR3 expression on NK cells
increased NK cell recruitment to the lungs, and the increased
NK cell recruitment in high-dose IAV infections correlated
with a higher expression of CXCR3 ligands in the lungs. CCR5
ligands were also upregulated in the lung and correlated with
an increased recruitment of WT NK cells to the lung tissue
and airways compared to CCR5−/− NK cells. Overall, our data
suggest that in addition to infection-dependent mechanisms of
NK cell recruitment to the lung, the severity of infection may also
influence the magnitude of NK cell recruitment, thus influencing
disease outcome.
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Mice

Six- to eight-week-old BALB/c and C57Bl/6 mice were purchased
from the National Cancer Institute (Frederick, MD). BALB.
B6-CT6 (i.e., CT6) mice were obtained from Dr. Anthony Scalzo
(Nedlands, Australia). CXCR3−/− (B6.129P2-Cxcr3tm1Djen/J),
CCR5−/- (B6.129P2-Ccr5tm1Kuz/J), and C57Bl/6 CD45.1 (B6.SJLPtprca Pepcb/BoyJ) were obtained from The Jackson Laboratory
(Bar Harbor, ME, USA) and bred in house. The C57Bl/6 CD45.1
colony was started prior to 2009 (25). C57BL/6 and C57Bl/6
CD45.1 mice were bred together to generate the CD45.1+/
CD45.2+ mice used in adoptive transfer experiments. All animals
were housed, bred, and maintained in the animal care facilities
at the University of Iowa. All procedures were approved by the
University of Iowa Animal Care and Use Committee.

Influenza Virus Infections

Mouse-adapted IAV A/PR/8/34 was grown in the allantoic fluid
of embryonated chicken eggs as previously described (26). Mice
were anesthetized with isofluorane and then infected i.n. with 50
µL of virus diluted in Iscove’s media as indicated. All experiments
with IAV were undertaken using BLS2/aBLS2 containment.

Influenza Virus Titers

Lungs were removed from infected mice at 2, 4, 6, and 8 days post
infection (p.i.) and homogenized. Viral titers were determined as
previously described by end point dilution assay and expressed
as TCIU. Briefly, 10-fold serial dilutions of lung homogenates
from IAV-infected mice were mixed with 2.5 × 104 Madin–Darby
canine kidney cells incubated at 37°C. After 24 h, culture supernatants were removed and fresh media were added to each well.
After 4 days of incubation, culture supernatants were mixed with
0.5% chicken RBC and the agglutination pattern was determined,
and the TCIU values were calculated using the Reed–Muench
accumulative method.

NK Cell Depletion

CT6 mice were administered 300 µg of anti-NK1.1 (PK136)
monoclonal antibody (mAb) intraperitoneally (i.p.) 2 days before
and on the day of IAV infection to deplete NK cells. NK depletion
was verified by flow cytometry using mAbs against NKp46 (clone
29A1.4) and CD3ε (clone 17A2).

NK Cell Purification

Spleens were processed with frosted glass slides to create a
single-cell suspension. Lymphocytes were separated from red
blood cells using a Ficoll gradient before NK cells were purified
using the EasySep Mouse NK Cell Enrichment kit (STEMCELL
Technologies, Vancouver, Canada) as per manufacturer’s
instructions. For the competitive trafficking assay WT (CD45.1+/
CD45.2+) and CXCR3−/− or CCR5−/− (CD45.2+) NK cells were
mixed 1:1 before transferring 100 µL i.v. to recipient mice
(CD45.1+) (1–5 × 105 each NK cell population). Mixed donor cells
were analyzed by flow cytometry prior to injection to determine
the actual ratio for that individual experiment. Endogenous,
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Iscove’s media, aliquoted, and stored at −80°C. DuoSet ELISA
kits (R&D Systems, Minneapolis, MN, USA) were used to determine CCL5, CXCL9, CXCL10, and CXCL11 (BALB/c only) per
manufacturer’s instructions.

transferred WT, and transferred CXCR3−/− or CCR5−/− NK cells
were identified by CD45.1 and CD45.2 expression by flow cytometry. For calculations of the ratio of donor NK cell trafficking, the
values observed for each of the donor NK cell populations were
normalized to the actual input ratio that was observed for the
mixed donor cells for that experiment.

RESULTS

Flow Cytometry

NK Cells Accumulate in the Lung and
Lung DLNs During IAV Infection

Lungs were digested in DNAse and Collagenase IV for 10 min at
37°C. Organs were processed through a 60-µm screen, and singlecell suspensions were blocked in 2% rat serum. The following antibodies were used for these studies: rat anti-mouse CD3ε (17A2),
hamster anti-mouse CD27 (LG.3A10), rat anti-mouse CD11b
(M1/70), rat anti-mouse CD49b (DX5), and mouse anti-mouse
CD45.2 (104) purchased from BD Biosciences (San Jose, CA, USA);
mouse anti-mouse NK1.1 (PK136) purchased from eBioscience
(San Diego, CA, USA); and mouse anti-mouse CD45.1 (A20) purchased from Biolegend (San Diego, CA, USA). For surface staining,
106 cells were incubated with antibody for 25 min at 4°C and then
fixed in FACS lysis buffer (BD Biosciences, San Jose, CA, USA). All
flow cytometry data were collected with a BD Canto II and data
analyzed with Flow Jo software (Tree Star, Inc., Ashland, OR, USA).

Prior studies examining the contribution of NK cells to IAV immunity have shown disparate results; studies using higher infection
doses found that NK cells contribute to lethal immunopathology,
while studies using lower doses of IAV showed a protective role
for NK cells (4–9, 12, 13). Therefore, to determine if the kinetics and location of NK cell trafficking during IAV infection are
altered by the severity and initial dose of IAV, BALB/c mice were
infected with either a high- (1 LD50) or a low (0.1 LD50)-IAV dose,
and NK cells were subsequently quantified in the lung, lung DLN,
and spleen by flow cytometry (see Figure 1A for representative
gating strategy). Following infection, the number of NK cells
found in the lung was significantly increased at days 2, 4, 6, and
8 p.i. in both the high- and low-dose infections when compared
to naïve mice (day 0) (p < 0.05, Student’s unpaired t-test), with
maximal accumulation at day 6 p.i. Moreover, NK cell numbers
in the lung were significantly greater in high- vs. low-dose IAVinfected lungs on days 4 and 6 p.i. (Figure 1B, left panel). Within
the DLN, the number of NK cells present was significantly higher
for IAV-infected mice than in naïve mice at days 2, 4, and 6 p.i.
NK cell accumulation peaked at day 4 p.i. for both doses of IAV
(Figure 1B, middle panel). However, while NK cell accumulation in the lungs was greater in high-dose IAV-infected mice,
accumulation in the DLN was instead significantly higher for the
low-dose IAV infection. In the spleen, NK cell numbers initially
increased at day 2 p.i. before returning to homeostatic levels in
low-dose IAV-infected mice and were significantly decreased
relative to naïve mice in high-dose IAV-infected mice (Figure 1B,
right panel). In summary, similar kinetics of NK cell trafficking
were observed between high- and low-dose IAV infections; however, the overall magnitude of NK cell accumulation differed with
a greater NK cell accumulation in the lungs during high-dose
IAV and in the DLN during low-dose IAV infection. Importantly,
C57Bl/6 mice infected with high and low doses of IAV showed
similar kinetics and organ preference in NK cell trafficking as
BALB/c mice (Figure 1B), suggesting that the pattern of NK cell
trafficking during IAV infection was not mouse strain-specific.
Natural killer cells can be subdivided into subsets by CD27
and CD11b expression (CD27+CD11b−, CD27+CD11b+, and
CD27−CD11b+) to correspond to different stages of maturation
(29). These NK cell subsets differ in effector molecule expression
as well as chemokine receptor expression (17, 29, 30). Therefore,
differential recruitment of the various NK cell subsets could correlate with their different roles in immunity (31) or in protection vs.
immunopathology during IAV infection. When we quantified the
recruitment of NK cell subsets within the lung, DLN, and spleen
of high- and low-dose IAV-infected mice, we observed increases
in all three NK subsets in the lung and DLN. In the lung, mature

NK Cell Proliferation Assay

For proliferation assays, A/PR/8/34-infected BALB/c mice were
administered 8 mM carboxyfluorescein succinimidyl ester
(CFSE) (50 µL) and 2 h later were given 80 µg bromodeoxyuridine (BrdU) i.n. as previously described (27). Four hours after
the BrdU administration, lungs were harvested and single-cell
suspensions were prepared for flow cytometric analysis with
anti-CD49b (DX5) and anti-CD3ε mAbs as described above.
Following cell fixation, BrdU incorporation was determined with
the BrdU Flow Kit (BD Biosciences San Jose, CA, USA) according
to manufacturer’s instructions. NK cells proliferating within the
lung were identified as DX5+CD3−CFSE+BrdU+ cells.

Drug Treatments

For the NK cell trafficking assay, A/PR/8/34-infected BALB/c mice
were administered 500 ng pertussis toxin (PT) (Sigma-Aldrich,
St. Louis, MO, USA) in 200 µL phosphate buffered saline (PBS)
i.p. on days 2, 3, 4, and 5 post IAV infection. For the competitive
NK cell trafficking experiment, purified NK cells from C57Bl/6
mice (CD45.2+) were incubated with 200 ng/mL PT in RPMI supplemented with 2% FBS for 20 min at 37°C while NK cells from
C57Bl/6 mice (CD45.1+/CD45.2+) were incubated in media + 2%
FBS as previously described (28). Cells were washed three times in
PBS and then mixed at a 1:1 ratio before transfer. Mixed donor cells
were analyzed by flow cytometry to determine the actual input
ratio for that individual experiment. For calculations of the ratio of
donor NK cell trafficking, the values observed for each of the donor
NK cell populations were normalized to the actual input ratio that
was observed for the mixed donor cells for that experiment.

ELISA

Lungs from A/PR/8/34-infected BALB/c and C57Bl/6 mice were
harvested at indicated days and were homogenized in 3 mL

Frontiers in Immunology | www.frontiersin.org

3

April 2018 | Volume 9 | Article 781

Carlin et al.

NK Cell Trafficking During IAV

Figure 1 | Kinetics of natural killer (NK) cell accumulation during high- and low-dose influenza A virus (IAV) infections. (A) Representative gating strategy for
DX5+CD3− NK cells in the lungs. (B) BALB/c (top) or C57Bl/6 (bottom) mice were infected with a high (1 LD50) or low (0.1 LD50) dose of A/PR/8/34. NK cells were
enumerated in the lung, lung-draining lymph node (DLN), or spleen at the indicated time points by flow cytometry. Shown are DX5+ or NK1.1+CD3ε− cells. The
number of NK cells in the DLN is expressed as NK cells per node. (C) NK cells (DX5+CD3ε− gated) within the lung, DLN, and spleen in BALB/c mice were further
characterized by CD27 and CD11b expression to determine the distribution of functional subsets during both high- (top) and low (bottom)-dose IAV infections.
Shown are p-values for high- vs. low-dose IAV infections. *p < 0.05, **p < 0.005, ***p < 0.001 (two-tailed unpaired Student’s t-test). The number of NK cells within
the lung of high- and low-dose IAV-infected mice was found to be significantly greater than the number of NK cells in naïve lungs at days 2, 4, and 6 p.i. (p < 0.05).
The decrease in NK cell numbers in the spleen was found to be significantly greater in high-dose-infected mice by two-way ANOVA (p < 0.001). Data are pooled
from at least two separate experiments, with five mice per time point, per experiment. (D) The fold increase in CD27+CD11b−, CD27+CD11b+, and CD27−CD11b+
NK cells within the lungs was calculated by dividing the cell number found with the lungs at the peak of the response by the cell number found within the lungs at
day 0.
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IAV infection and have shown that the main site of NK cell
proliferation is the bone marrow, and only a small percentage of
NK cells within the lung incorporate BrdU (33, 34). However,
these studies did not directly differentiate between NK cells
proliferating within the lung and NK cells proliferating in the
periphery before being recruited to the lung. Further, it remains
unknown as to what effect the initial dose of IAV has on NK cell
proliferation. To quantify NK proliferation specifically within the
lung, we used a CFSE followed by BrdU dual-labeling method
that we have previously described (27) (Figure 2A). This labeling
technique utilizes i.n. CFSE administration to tag cells within the
lungs followed by a subsequent BrdU labeling to identify cells
that have proliferated within the local lung environment. We
observed NK cell proliferation in the lung during both high- and
low-dose infections, which peaked at day 4 p.i. When comparing
high- to low-IAV infection doses, we observed significantly more
NK cells proliferating within the lungs of high-dose-infected
mice at day 6 p.i. (Figure 2B). While viral dose affected the
overall number of proliferating NK cells, similar frequencies
of proliferating NK cells were observed between the two virus
doses (Figure 2C), suggesting that the difference observed in the
number of proliferating NK cells was reflective of the difference
in the total number of NK cells recruited to the lungs, rather than
a direct effect of the initial dose of virus on NK cell proliferation
itself (Figures 1 and 2C). While our results demonstrate lungspecific NK cell proliferation for the first time, it should be noted
that the proportion of NK cells proliferating within the lung is
very low when compared to IAV-specific T cell proliferation at
these same time points (Figure 2A) (27). At the peak of NK cell
proliferation, approximately 2% of NK cells within the lung were
found to be CFSE+BrdU+, while at the same time point, 55–75%
of IAV-tetramer+ CD8 T cells (27) and 7–8% of all CD3ε+ T cells
(Figure 2A) within the lung are CFSE+BrdU+. Finally, although
we observed NK cell proliferation within IAV-infected lungs, it
is clear that the number of proliferating NK cells and the associated cell expansions could not account for the total increase in
NK cell numbers observed within the lung. These data suggest
that NK cell recruitment from the periphery into the lung is the
main contributor to NK cell accumulation observed in both highand low-dose IAV-infected lungs.

CD27−CD11b+ NK cells accumulated in the greatest number in
both the high- and low-dose infections (Figure 1C); however, the
intermediate CD27+CD11b+ subset showed the greatest relative
increase in magnitude (Figure 1D). The immature CD27+CD11b−
NK cells also increased in number within the infected lung, but
showed no significant difference between high- and low-dose
infections (p > 0.05) (Figure 1C, left panels), suggesting that the
CD27+CD11b− NK cell subset did not contribute to the overall
difference in NK cell numbers observed in the lungs between
high- and low-dose IAV infections. Similar to studies utilizing a
single dose of IAV (32), the accumulation of all three NK subsets
was also observed in the DLN of both high- and low-dose IAVinfected mice. NK cell subsets were evenly distributed within the
DLN, and all NK cell subsets had a maximal accumulation at day
4 p.i. (Figure 1C, middle panels)—a kinetics which is in excellent
agreement with those recently reported (31). Unlike what was
observed in the lung and DLN, where all NK cell subset numbers
increased within the tissues, only the CD27−CD11b+ NK cell
subset had altered kinetics in the spleen during the course of both
high- and low-dose IAV infection. The number of CD27−CD11b+
NK cells decreased in both infection doses (Figure 1C, right panels). Notably, the CD27−CD11b+ subset had the greatest increase
in the lung, while it had the greatest decrease within the spleen,
suggesting that NK cell accumulation within the lung during IAV
infection may be due, in part, to recruitment of this NK cell subset
from the spleen.
As expected, based on our prior studies (26), despite the differing accumulation level of NK cells during high- and low-dose
infections, we observed no differences in IAV virus titers in the
lungs on day 2, 4, 6, or 8 p.i. (Data Sheet S1 in Supplementary
Material). Further, when we depleted NK cells from BALB.CT6
mice (BALB/c mice that express NK1.1), we did not observe
changes in overall morbidity and mortality (Data Sheet S1 in
Supplementary Material). This suggests that in the absence of
NK cells, or when infection conditions lead to differing magnitudes of NK cell accumulation within lungs (Figure 1), other
immune cell populations may compensate to control virus loads
and dictate the outcome of the infection.

NK Cell Accumulation in the Lung During
IAV Infection Is Not due to Apoptosis or
Proliferation

NK Cells Are Recruited to the Lung
and DLN via Chemokine Receptors

Since we observed differential trafficking of NK cells during
high- and low-dose IAV infections, we next sought to determine
the mechanism(s) regulating this trafficking. The difference in
accumulation within the lung between high- and low-dose IAV
infections could be due to at least three potential mechanisms:
differential levels of (1) apoptosis, (2) proliferation, and/or
(3) recruitment. When we examined the level of apoptosis of
NK cells via active caspase 3/7 and 7-AAD staining, we observed
that less than 0.5% of the NK cells were undergoing apoptosis
(i.e., caspase 3/7+7–AAD+) in either the high- or low-dose
IAV-infected lungs on day 4 p.i. (not shown). This suggested
that differential apoptosis likely does not explain the differing
accumulation of NK cells in the lungs after high- and low-dose
IAV. Previous studies have examined NK cell proliferation during
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As NK cell proliferation within the lung could not account for the
total NK cell accumulation observed, we next determined if NK cells
were recruited to the lung during IAV infection via chemokine
receptors. Chemokine receptors are G protein-coupled receptors
whose activation is required for gradient-directed recruitment
of cells into tissues. To determine if chemokine receptors were
necessary for NK cell accumulation within the IAV-infected lung,
chemokine receptor activation was blocked by administering PT,
an inhibitor of G protein-coupled receptors (35), to mice infected
with either a high or a low dose of IAV. PT significantly decreased
the number of NK cells in the lungs of both groups of IAV-infected
mice (Figure 3A). Further, blocking chemokine receptor activation did not selectively inhibit the recruitment of a specific subset
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Figure 2 | Small frequency of natural killer (NK) cells proliferate in the lung during low- and high-dose influenza A virus (IAV) infections. BALB/c mice were infected
with either a high- or low-dose IAV infection and administered carboxyfluorescein succinimidyl ester (CFSE) and bromodeoxyuridine (BrdU) intranasally on the day of
analysis, as described in Section “Materials and Methods.” (A) Representative flow plots for NK cells (DX5+CD3ε− gated) and T cells (DX5−CD3ε+ gated) in the lungs
of day 4 or 6 low-IAV dose-infected mice. The (B) number and (C) frequency of proliferating NK cells (i.e., the percentage of all DX5+CD3ε− cells that were also
CFSE+BrdU+) was determined by flow cytometry. The p-values comparing high- vs. low-dose IAV-infected animals are shown. *p < 0.05 (two-tailed unpaired
Student’s t-test). Data are pooled from three high-dose experiments and two low-dose experiments, with five mice per group, per time point.

of NK cells, as there was no change in the subset distribution
between PBS- and PT-treated mice (Figure 3B). Notably, while
PBS-treated mice infected with a high dose of IAV had significantly
more NK cells in the lungs at day 6 p.i. than low-dose-infected
mice (Figures 1 and 3A), there was no difference in the number
of NK cells between high- and low-dose infections in PT-treated
mice, suggesting that the difference in NK cell accumulation in
the lung between high- and low-dose infections in non-PT treated
mice is likely due to enhanced recruitment via chemokine receptors. No difference was observed in NK cell numbers within the
DLN or spleens between PT- and PBS-treated mice, suggesting
that the difference in NK cell accumulation observed within the
lung was due to a decreased trafficking, rather than a toxic effect
of PT treatment (Figure 3C).
To determine a more specific role for chemokine receptors on
NK cells in NK cell trafficking during IAV infection, NK cells from

Frontiers in Immunology | www.frontiersin.org

CD45 congenic mice were incubated with PT (CD45.1−CD45.2+)
or PBS (CD45.1+CD45.2+) prior to adoptive transfer into IAVinfected hosts (CD45.1+CD45.2−) (Figure 4A). We observed
a significant reduction in PT-treated NK cell trafficking to the
lung compared to PBS-treated donor NK cells in high-dose IAVinfected mice at day 4 p.i. and in low-dose IAV-infected mice
at day 6 p.i. (i.e., lower numerical ratio as a result of a reduced
recruitment of PT-treated donor cells compared to PBS-treated
NK cells, Figure 4B). In contrast to our findings in vivo in
PT-treated mice, in vitro PT-treated NK cell trafficking to the
DLN was significantly reduced compared to PBS-treated NK cells
in both high- and low-dose IAV-infected mice on days 4 and 6 p.i.
(Figure 4B). The reduced trafficking of PT-treated NK cells into
the DLN at day 6 p.i. (Figure 4B) suggests that while the overall
number of NK cells in the DLN is decreasing at that time, there
is still a detectable influx of NK cells and that trafficking into the

6

April 2018 | Volume 9 | Article 781

Carlin et al.

NK Cell Trafficking During IAV

Figure 3 | Blockade of chemokine receptor-mediated recruitment results in decreased natural killer (NK) cell accumulation in the influenza A virus (IAV)-infected
lung. BALB/c mice were infected with either a high or a low dose of IAV and administered a 500 ng/200 μl intraperitoneal injection of pertussis toxin (PT) or 200 µL
phosphate buffered saline (PBS) on days 2, 3, 4, and 5 post infection (p.i.). On day 6 p.i., lungs (A), draining lymph node (DLN) (per node) (C), and spleens (C) were
harvested from high-dose-infected mice or low-dose-infected mice, and the number and frequency of NK cells (DX5+CD3ε− gated) were determined by flow
cytometry. (B) NK cells (DX5+CD3ε− gated) in the lung were further characterized by CD27 and CD11b expression to determine changes in functional NK subset
distribution. Shown are the p-values comparing PT-treated mice to PBS-treated mice. **p < 0.005, ***p < 0.001 (two-tailed unpaired Student’s t-test). Data are
pooled from three high-dose experiments and two low-dose experiments, with five mice per group.

DLN at later time points is mediated by chemokine receptors.
No difference in NK cell trafficking to the spleen was observed
(Figure 4B). These data further support a role for chemokine
receptor-mediated trafficking of NK cells to the lungs and DLN
during IAV infection.

receptors were used for NK cell trafficking to the IAV-infected
lung. CXCR3 is an important chemokine receptor for NK cell
homing in homeostasis (20), and the receptor is used by CD8
T cells to migrate into the IAV-infected lung (23). Therefore, to
determine if CXCR3 was necessary for NK cell recruitment to
the IAV-infected lung, we again utilized a competitive trafficking
assay. Donor congenic WT CXCR3+/+ (CD45.1+CD45.2+) and
CXCR3−/− (CD45.1−CD45.2+) NK cells were transferred into
IAV-infected CXCR3+/+ hosts (CD45.1+CD45.2−) (Figure 5A).
There was a significant decrease in CXCR3−/− NK cell trafficking
compared to donor WT NK cell trafficking (i.e., KO:WT ratio <1)
to the lung and DLN in high-dose-infected mice and to the lungs

CXCR3 Expression on NK Cells Increases
NK Cell Recruitment to the Lungs and
DLN of IAV-Infected Mice

Since our results implicate chemokine receptors in NK cell
accumulation in the lung, we determined which chemokine
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Figure 4 | Inhibition of chemokine receptor signaling in natural killer (NK) cells results in a decreased accumulation in the lungs and draining lymph nodes (DLNs) of
influenza A virus (IAV)-infected mice. C57Bl/6 (CD45.1) host mice were infected with a high- or low-dose of IAV. 1 × 105 donor C57Bl/6 NK cells treated with
pertussis toxin (PT) (CD45.2+) and 1 × 105 C57Bl/6 NK cells treated with phosphate buffered saline (PBS) (CD45.1+CD45.2+) were transferred into infected host
mice for 16–18 h before analysis (i.e., transferred on day 3 p.i. for day 4 analysis, or day 5 p.i. for day 6 analysis). A group of non-NK cell transferred mice was used
as a control. (A) Representative flow plots for NK cells (NK1.1+CD3ε−) on day 4 p.i. in high-dose IAV lungs, DLN, and spleen showing host (CD45.1+CD45.2−),
PBS-treated donor (CD45.1+CD45.2+), and PT-treated donor (CD45.1−CD45.2+) NK cells. (B) the normalized ratio of PT-treated NK cells to PBS-treated control
NK cells in the lungs, DLN, and spleen of infected recipients is shown. Note: equal trafficking between PBS- and PT-treated NK cells = 1, an increased PT-treated
NK cell trafficking >1, and a decreased PT-treated NK cell trafficking <1. p-values comparing PT-treated NK cell trafficking with PBS-treated cells within the same
group are shown. #p < 0.05, ###p < 0.001 (two-tailed paired Student’s t-test). *p < 0.05 represents comparison of the PT/PBS ratios between the indicated groups.
High- and low-dose experiments were performed once with four mice per group.

of low-dose-infected mice (Figure 5B). Notably, the ratio of
recruitment of donor CXCR3−/− to CXCR3+/+ NK cell was also
significantly reduced in high-dose compared to low-dose IAVinfected mice at day 6 p.i. (Figure 5B), suggesting that CXCR3
expression on NK cells could be more important for recruitment
to the lung in high-dose IAV infections. Therefore, the amount of
CXCR3 ligands, CXCL9, CXCL10, and CXCL11, was quantified

Frontiers in Immunology | www.frontiersin.org

in the lungs of high- and low-dose-infected mice (Figure 6) to
determine if differences in ligand expression correlated with
the differences observed in the competitive trafficking assay
(Figure 5B). All CXCR3 ligands were significantly increased in
the lungs of high-dose compared to low-dose-infected BALB/c
mice at day 2 p.i., while only CXCL11 was expressed in higher
amounts from days 2 to 6 p.i. (Figure 6A). Similarly, CXCL9
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Figure 5 | CXCR3 expression by natural killer (NK) cells increases NK cell trafficking to the lung and draining lymph node (DLN) during influenza A virus (IAV)
infection. C57Bl/6 (CD45.1) host mice were infected with a high or a low dose of IAV. 5 × 105 donor WT C57Bl/6 (CD45.1/CD45.2) and 5 × 105 CXCR3−/− (CD45.2)
NK cells were transferred into infected host mice for 16–18 h before analysis. (A) Representative flow plots for NK cells (NK1.1+CD3ε−) on day 6 post infection (p.i.)
in high- or low-dose IAV lungs showing host (CD45.1+CD45.2−), WT donor (CD45.1+CD45.2+), and CXCR3−/− donor (CD45.1−CD45.2+) NK cells. (B) The normalized
ratio of CXCR3−/− NK cells to WT NK cells in the lungs, DLN, and spleen of infected recipients is shown. Note: equal trafficking between WT and CXCR3−/−
NK cells = 1. p-values comparing WT to CXCR3−/− NK cell trafficking (two-tailed paired Student’s t-test) within the same group are shown. #p < 0.05, ###p < 0.001,
and comparing, as indicated, the CXCR3−/− NK cells:WT NK cell ratio between high- and low-dose IAV-infected mice or by time post infection. *p < 0.05,
***p < 0.001. Data are pooled from two high-dose experiments and three low-dose experiments, with five mice per group.

and CXCL10 were significantly greater in the lungs of high-dose
vs. low-dose-infected C57Bl/6 mice at both days 2 and 4 p.i.
(Figure 6B). The increased amount of CXCR3 ligand found in
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the lungs of mice receiving a high-dose of IAV correlated with
the reduced CXCR3−/− NK cell trafficking that was observed in
high-dose IAV-infected mice (Figure 5B).
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Figure 6 | CXCR3 ligands are upregulated in the lungs during influenza A virus (IAV) infection and expressed at higher levels in the lungs of high-dose-infected
mice. (A) BALB/c and (B) C57Bl/6 mice were infected with either a high- or low-dose IAV. Lungs were homogenized, and the levels of CXCL9, CXCL10, and
CXCL11 [not expressed (N/A) in C57Bl/6 mice] were quantified by ELISA. p-values comparing chemokine levels in high- vs. low-dose IAV-infected mice are shown.
*p < 0.05, **p < 0.005, ***p < 0.001 (two-tailed unpaired Student’s t-test). BALB/c data are pooled from two separate experiments with at least five mice per group.
C57Bl/6 data are representative of one experiment with at least three mice per group.

CCR5 Localizes NK Cells to IAV-Infected
Epithelium

(20), it is not known if or how NK cells are localized to infected
epithelial cells. Similar to NK cells, CXCR3 expression on CD8
T cells increases their recruitment to the lung during IAV infection (23). However, once in the lungs, CCR5 is required for

While our above studies and others suggest that CXCR3 aids in
NK cell recruitment to both the naïve- and IAV-infected lung
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student’s unpaired t-test). Therefore, we hypothesized that
CCR5 expression on NK cells would be required for localization
to the infected epithelium. Previously, it had been shown that
IAV-infected CCR5−/− mice have less NK cell accumulation in
the lung than IAV-infected WT mice (15). However, this defect
in NK cell recruitment could be due to a requirement for CCR5
in NK cell recruitment to the IAV-infected lung, or due to the
known proliferative defects of CCR5−/− NK cells, which results
in decreased NK cell numbers in the periphery of naïve mice
(15). To more directly test if CCR5 was required for NK cell
accumulation in the IAV-infected lung, CCR5−/− NK cells
(CD45.1−CD45.2+) and WT NK cells (CD45.1+CD45.2+) were
adoptively transferred into high-dose IAV-infected WT C57Bl/6
recipients (CD45.1+CD45.2−) (Figure 7B). A significant decrease
in the accumulation of CCR5−/− NK cells compared to WT

memory CD8 T cell localization to the IAV-infected airway (22).
Ligands for CCR5 (CCL3, CCL4, and CCL5) are upregulated
in the lung of both BALB/c and C57Bl/6 mice [Figure 7A (36,
37)]. Interestingly, while similar trends in CXCR3 ligands were
observed between BALB/c and C57Bl/6 mice, the pattern of
relative CCL5 expression appeared to be inverted at later time
points. While CCL5 was significantly upregulated at day 2 in
high-dose IAV-infected lungs in both strains, CCL5 continued
to have a higher expression in high-dose IAV-infected lungs in
C57Bl/6 mice, while CCL5 expression was significantly higher
in low-dose IAV-infected BALB/c mice (Figure 7A). Despite
the difference in expression pattern, CCL5 was significantly
upregulated in the lungs compared to naïve mice on days 2–8
during high-dose IAV infection and on days 4–8 during lowdose IAV infections for both mouse strains (Figure 7A, p < 0.05,

Figure 7 | CCL5 is upregulated in the lungs during high- and low-dose influenza A virus (IAV) infections. (A) BALB/c (left) and C57Bl/6 (right) mice were infected
with high- and low-dose A/PR/8/34. Lungs were harvested at indicated time points, and CCL5 in supernatants was quantified by ELISA. Uninfected mice were used
as naïve controls. p-values comparing CCL5 levels in high- vs. low-dose IAV-infected mice are shown. Data were obtained from samples as in Figure 6. (B,C)
C57Bl/6 (CD45.1) host mice were infected with a high dose of IAV. 3 × 105 donor WT C57Bl/6 (CD45.1/CD45.2) and 3 × 105 CCR5−/− (CD45.2) natural killer (NK)
cells were transferred into infected host mice for 16–18 h before analysis. (B) Representative flow plots for NK cells (NK1.1+CD3ε−) in the bronchoalveolar lavage
(BAL) vs. lung tissue showing host (CD45.1+CD45.2−), WT donor (CD45.1+CD45.2+), and CCR5−/− donor (CD45.1−CD45.2+) NK cells. (C) Shown is the normalized
ratio of CCR5−/− NK cells to WT NK cells in the lungs or BAL fluid of infected recipients. Data are from one experiment with six mice per group. Note: equal
trafficking between WT and CCR5−/− NK cells = 1. p-values comparing WT to CCR5−/− NK cell trafficking (two-tailed paired Student’s t-test) within the same group
are shown. ###p < 0.001 and comparing the ratio of CCR5−/−/WT NK cell trafficking in the BAL vs. lung tissue. ***p < 0.001.
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NK cells in the lung tissue (i.e., ratio <1, Figure 7C) was observed
at day 6 p.i. To further determine if CCR5 was used for NK cell
localization within the IAV-infected lungs, CCR5−/− and WT
NK cell accumulation within the bronchoalveolar lavage fluid
was determined. The ability of CCR5−/− NK cells to traffic to the
IAV-infected airway was significantly reduced compared to WT
NK cells (Figure 7C), and the ability of CCR5−/− NK cells to traffic
to the airway was significantly reduced compared to lung tissue,
suggesting that while CCR5 may aid in NK cell recruitment to
the lung tissue, it is also important for NK cell localization to the
infected epithelium.

in the lung is largely due to a directed recruitment rather than a
local proliferation.
CXCR3 is important for NK cell trafficking to the lung both
in homeostasis and in bacterial infection (20, 21). Herein, we
show that CXCR3 also plays a role in recruiting NK cells to the
lung during IAV infection, as CXCR3−/− NK cells did not traffic
to the lung as efficiently as WT NK cells. The difference between
WT and CXCR3−/− NK cell trafficking was more pronounced in
mice infected with a high-dose IAV infection, and CXCR3 ligands
were significantly higher in the lungs of high-dose compared
to low-dose IAV-infected mice. Whether CXCR3 plays a more
dominant role in NK cell recruitment during high-dose IAV
infections or is solely responsible for the increased accumulation of NK cells within high-dose IAV-infected lungs remains
to be determined. Importantly, although CXCR3−/− NK cells
had significantly reduced recruitment compared to CXCR3+/+
NK cells, CXCR3−/− NK cells did accumulate in IAV-infected
lungs. This suggests that the recruitment of NK cells to the lung
during IAV infection may be multifactorial, most likely utilizing
several chemokine receptors. Indeed, we have shown herein that
CCR5 is also used for NK cell recruitment to the IAV-infected
lung (Figure 7C). CCR5−/− NK cells had impaired accumulation
to the IAV-infected lung compared to WT NK cells; however, the
decrease in CCR5−/− NK cell accumulation was not as significant
as the decrease in CXCR3−/− NK cells accumulation when compared to WT NK cells (Figures 5B and 7C). In addition to CXCR3
and CCR5, CCR2 is important for NK cell trafficking during IAV
infection. While others have shown that CCR2 on NK cells does
not affect accumulation within the IAV-infected lung tissue, it is
used by NK cells to traffic to the IAV-infected airways (19). It is
possible that CCR2, among other chemokine receptors, is able to
compensate for the loss of CXCR3 or CCR5 in NK cell migration
to the IAV-infected lung.
Our experiments utilizing PT treatment to inhibit NK cell
trafficking resulted in opposing findings within the DLN, where
NK cell accumulation was not affected in PT-treated mice, but
was significantly inhibited when NK cells were treated with PT
in vitro. Chemokine receptor signaling is required for both cell
recruitment to organs and cell egress from organs. CXCR3 has
been shown to increase NK cell recruitment to inflammation
DLNs, while S1P5 and homeostatic chemokines are utilized
for NK cell egress from lymph nodes (31, 32, 40, 41). By
treating mice with PT for 4 days in vivo prior to analysis, we
likely uncoupled these two processes, and it is not possible to
determine if the lack of difference observed in NK cell numbers
in the DLN between in vivo PT and PBS-treated mice is due to
changes in recruitment to or egress from the lymph node. As
the adoptive transfer model examines NK cell recruitment for
16–18 h after transfer, we are more likely to be observing NK cell
recruitment to the DLN, rather than recruitment and egress.
While the number of NK cells in the DLN begins to decrease by
day 6 p.i. (Figure 1B), NK cell recruitment to the DLN could still
be occurring at day 5 p.i., when PBS- and PT-treated NK cells
were adoptively transferred to IAV-infected hosts. Finally,
NK cells in in vivo PT- and PBS-treated mice had been exposed
to inflammation for 5 days prior to analysis, while in vitro
PBS- and PT-treated NK cells were adoptively transferred into

DISCUSSION
Our results show that NK cells are actively recruited to the lung
and lung DLN during IAV infection, consistent with previous
studies (5). However, herein, we show preferential organ-specific
recruitment (31, 38, 39) that is dependent on the dose of infection.
Recruitment to the lung is increased in high-dose IAV infections,
and accumulation of NK cells within the DLN is increased in lowdose IAV infections. Importantly, studies have shown disparate
roles for NK cells in immunity against IAV, with NK cells playing
a protective role in lower-dose IAV infections and contributing
to lethal pathology in lethal dose infections (5, 8, 9, 12, 13). While
the results presented herein argue for differential NK cell recruitment and trafficking based on the IAV infection dose, they also
suggest that such differences may not alter pulmonary virus titers
from days 2 to 8 p.i. Furthermore, our results show that the loss
of NK cells prior to both high- and low-dose IAV infections does
not alter IAV morbidity or mortality. However, at this time, it is
difficult to interpret the direct contribution of NK cells to the
overall virus control and pathology as compensatory changes in
other immune cell populations that contribute to these aspects
occur in the absence of NK cells or during different infection
doses. For example, our preliminary studies suggest that IAVspecific CD4 T cell responses may be increased in the absence
of NK cells (not shown). Furthermore, our prior studies have
demonstrated reduced levels of IAV-specific CD8 T cells in the
lungs of 1LD50 dose vs. 0.1 LD50 dose IAV-infected mice (26).
Therefore, future studies determining if the magnitude of the
NK cell response within the lungs or DLN is a significant contributor to pathology or virus control in both high- and low-dose
IAV infections will also need to assess the modulation of other
immune cell populations critical to IAV immunity and pathology
at the same time.
Herein, we show for the first time that there is a lung-specific
NK cell proliferation during IAV infection by labeling pulmonary
cells with CFSE in addition to intranasal BrdU administration. Our
results are consistent with other studies that administered BrdU
systemically (33, 34) and in vitro NK cell: alveolar macrophage
co-cultures (10). Further, we show that NK cell proliferation
within the lung is not dependent on IAV virus titers, as the same
frequency of NK cells proliferated within the lung during both
high- and low-dose IAV infections. Our findings that NK cell
proliferation within the lung does not account for the total accumulation of NK cells and that PT treatment decreases NK cell
accumulation within the lung suggest that NK cell accumulation
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